• About

  • Services

  • Contact

  • Blog

  • More

    Use tab to navigate through the menu items.
    Recent Posts
    • LinkedIn Social Icon
    Diligentia President, Joff Masukawa, will serve as a panelist at the Virginia Bioscience Commerciali

    Diligentia President, Joff Masukawa, will serve as a panelist at the Virginia Bioscience Commerciali

    Joff Masukawa, Diligentia Strategy, will be the featured speaker at the November 3rd Virginia Bioscience Commercialization Luncheon. He will address commercialization strategies for biopharmaceuticals with a focus on the marketplace for rare diseases, orphan drugs, and specialty pharmaceuticals. If you are attending the luncheon and would like to learn about how Diligentia can support your commercial business objectives, email us at joff@diligentiastrategy.com. Click here to

    What is the impact of rare diseases on individuals and health care systems?

    Congressionally funded report details diagnostic challenges  and costs of rare diseases in the US

    Congressionally funded report details diagnostic challenges and costs of rare diseases in the US

    Diagnostics: Moving to the forefront of Global Healthcare

    Diagnostics: Moving to the forefront of Global Healthcare

    Economic Burden of Rare Diseases Nearly $1 Trillion

    Economic Burden of Rare Diseases Nearly $1 Trillion

    CBO Comparison of Brand-Name Drug Prices Among Selected Federal Programs

    CBO Comparison of Brand-Name Drug Prices Among Selected Federal Programs

    Orphan drugs account for more than half of all FDA drug approvals in 2020

    Orphan drugs account for more than half of all FDA drug approvals in 2020

    Rare Disease Stakeholders: Do mRNA COV19 Vaccines Affect Eligibility to Receive Future Gene Therapy?

    Rare Disease Stakeholders: Do mRNA COV19 Vaccines Affect Eligibility to Receive Future Gene Therapy?

    How do we identify and measure value for patients with rare diseases?

    How do we identify and measure value for patients with rare diseases?

    National Burden of Rare Disease Survey

    HVH Precision Analytics and Diligentia Strategy Announce Upcoming Presentation at the 2020 American

    HVH Precision Analytics and Diligentia Strategy Announce Upcoming Presentation at the 2020 American

    © 2021 Diligentia LLC

    Back to top

    (202) 744-0755